QuidelOrtho CorpNASDAQ:QDEL
- LAST PRICE37.5050
- TODAY'S CHANGE (%)1.3250 (3.6622%)
- Bid / Lots37.4300/ 7
- Ask / Lots37.5000/ 1
- Open / Previous Close35.8700 / 36.1800
- Day Range
- 52 Week Range
- Volume384,195
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | QDEL |
|---|---|---|
| 09:32 ET | 8813 | 35.6 |
| 09:33 ET | 107 | 35.89 |
| 09:35 ET | 100 | 35.89 |
| 09:37 ET | 200 | 35.875 |
| 09:44 ET | 1782 | 36.37 |
| 09:46 ET | 500 | 36.31 |
| 09:50 ET | 957 | 36.41 |
| 09:51 ET | 5593 | 36.58 |
| 09:55 ET | 400 | 36.575 |
| 09:57 ET | 6695 | 36.63 |
| 10:00 ET | 100 | 36.66 |
| 10:02 ET | 8524 | 36.98 |
| 10:08 ET | 3752 | 37.13 |
| 10:09 ET | 500 | 37.13 |
| 10:11 ET | 2835 | 37.2475 |
| 10:13 ET | 3675 | 37.275 |
| 10:15 ET | 1588 | 37.27 |
| 10:18 ET | 8246 | 37.56 |
| 10:20 ET | 200 | 37.56 |
| 10:22 ET | 6994 | 37.54 |
| 10:24 ET | 12399 | 37.65 |
| 10:26 ET | 2817 | 37.55 |
| 10:27 ET | 604 | 37.71 |
| 10:29 ET | 4724 | 37.53 |
| 10:31 ET | 1350 | 37.52 |
| 10:33 ET | 700 | 37.63 |
| 10:36 ET | 3544 | 37.76 |
| 10:38 ET | 547 | 37.7 |
| 10:40 ET | 200 | 37.65 |
| 10:42 ET | 1110 | 37.56 |
| 10:44 ET | 400 | 37.635 |
| 10:45 ET | 1424 | 37.58 |
| 10:47 ET | 500 | 37.51 |
| 10:51 ET | 1400 | 37.44 |
| 10:54 ET | 750 | 37.46 |
| 10:56 ET | 659 | 37.3089 |
| 10:58 ET | 350 | 37.385 |
| 11:00 ET | 100 | 37.37 |
| 11:02 ET | 257 | 37.355 |
| 11:03 ET | 9534 | 37.39 |
| 11:05 ET | 600 | 37.46 |
| 11:07 ET | 100 | 37.435 |
| 11:12 ET | 634 | 37.48 |
| 11:14 ET | 700 | 37.51 |
| 11:16 ET | 1502 | 37.46 |
| 11:18 ET | 3838 | 37.28 |
| 11:20 ET | 660 | 37.275 |
| 11:21 ET | 300 | 37.24 |
| 11:23 ET | 633 | 37.235 |
| 11:25 ET | 1600 | 37.2 |
| 11:27 ET | 2676 | 37.34 |
| 11:30 ET | 300 | 37.31 |
| 11:32 ET | 100 | 37.31 |
| 11:34 ET | 400 | 37.4 |
| 11:36 ET | 200 | 37.38 |
| 11:38 ET | 3965 | 37.215 |
| 11:39 ET | 411 | 37.225 |
| 11:41 ET | 300 | 37.25 |
| 11:43 ET | 500 | 37.245 |
| 11:45 ET | 500 | 37.285 |
| 11:48 ET | 3095 | 37.16 |
| 11:50 ET | 400 | 37.16 |
| 11:52 ET | 2500 | 37.15 |
| 11:54 ET | 890 | 37.15 |
| 11:56 ET | 100 | 37.145 |
| 11:57 ET | 2869 | 37.145 |
| 11:59 ET | 100 | 37.19 |
| 12:01 ET | 1900 | 37.09 |
| 12:03 ET | 2089 | 37.095 |
| 12:06 ET | 4733 | 37.1 |
| 12:08 ET | 2935 | 36.99 |
| 12:10 ET | 700 | 36.995 |
| 12:14 ET | 1000 | 37.0675 |
| 12:15 ET | 500 | 37.07 |
| 12:17 ET | 600 | 37.075 |
| 12:19 ET | 623 | 37.135 |
| 12:21 ET | 200 | 37.16 |
| 12:24 ET | 530 | 37.145 |
| 12:26 ET | 3396 | 36.985 |
| 12:28 ET | 903 | 37.01 |
| 12:30 ET | 300 | 37 |
| 12:32 ET | 5106 | 37.095 |
| 12:33 ET | 400 | 37.085 |
| 12:35 ET | 1466 | 37.12 |
| 12:37 ET | 1669 | 37.1 |
| 12:39 ET | 712 | 37.11 |
| 12:42 ET | 300 | 37.15 |
| 12:44 ET | 800 | 37.13 |
| 12:46 ET | 1028 | 37.16 |
| 12:48 ET | 200 | 37.17 |
| 12:50 ET | 1000 | 37.18 |
| 12:51 ET | 300 | 37.17 |
| 12:53 ET | 2015 | 37.17 |
| 12:57 ET | 1614 | 37.18 |
| 01:02 ET | 300 | 37.18 |
| 01:04 ET | 3634 | 37.175266 |
| 01:06 ET | 200 | 37.22 |
| 01:08 ET | 3409 | 37.155 |
| 01:09 ET | 900 | 37.11 |
| 01:11 ET | 203 | 37.155 |
| 01:13 ET | 204 | 37.15 |
| 01:15 ET | 1700 | 37.15 |
| 01:18 ET | 600 | 37.17 |
| 01:20 ET | 783 | 37.17 |
| 01:22 ET | 800 | 37.14 |
| 01:24 ET | 2000 | 37.23 |
| 01:26 ET | 1000 | 37.28 |
| 01:27 ET | 300 | 37.235 |
| 01:29 ET | 3883 | 37.24 |
| 01:31 ET | 8551 | 37.46 |
| 01:33 ET | 1378 | 37.46 |
| 01:36 ET | 4109 | 37.505 |
Nov 13, 2024
Kuehn Law Encourages Investors of QuidelOrtho Corporation to Contact Law Firm, from 12:39PM ET on Wednesday Nov 13, 2024 by Dow Jones
12:39PM ET on Wednesday Nov 13, 2024 by Dow Jones
Nov 8, 2024
DJ QuidelOrtho Up Over 14%, on Pace for Largest Percent Increase Since June 2020 -- Data Talk, from 11:57AM ET on Friday Nov 08, 2024 by Dow Jones
11:57AM ET on Friday Nov 08, 2024 by Dow Jones
Nov 7, 2024
QuidelOrtho Reports Third Quarter 2024 Financial Results, from 4:05PM ET on Thursday Nov 07, 2024 by Dow Jones
4:05PM ET on Thursday Nov 07, 2024 by Dow Jones*DJ QuidelOrtho 3Q Loss/Shr 30c >QDEL, from 4:05PM ET on Thursday Nov 07, 2024 by Dow Jones
4:05PM ET on Thursday Nov 07, 2024 by Dow Jones
Oct 31, 2024
Kuehn Law Encourages Investors of QuidelOrtho Corporation to Contact Law Firm, from 2:17PM ET on Thursday Oct 31, 2024 by Dow Jones
2:17PM ET on Thursday Oct 31, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
QuidelOrtho Corp | 2.4B | -1.3x | --- |
Bruker Corp | 7.8B | 23.8x | +20.48% |
Evolent Health Inc | 1.4B | -13.6x | --- |
Veradigm Inc | 1.1B | 11.4x | +42.05% |
Integer Holdings Corp | 4.5B | 41.4x | +8.57% |
Omnicell Inc | 2.1B | -117.9x | --- |
Company Information
QuidelOrtho Corporation is engaged in vitro diagnostics, developing and manufacturing intelligent solutions. The Company sells its products directly to end users through a direct sales force and through a network of distributors, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, other point-of-care (POC) settings, blood banks and donor centers, as well as for individual, non-professional, over the counter (OTC) use. The Company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Connect, Ortho Plus, Ortho Vision, QuickVue, Quidel, QuidelOrtho, QVue, Savanna, Sofia, Solana, Thyretain, Triage, Virena, Vitros among others. It provides support for its customers across more than 130 countries and territories.
Contact Information
- Headquarters
- 9975 Summers Ridge RoadSAN DIEGO, CA, United States 92121
- Phone
- 858-552-1100
- Fax
- 858-453-4338
Executives
- Lead Independent Director
- Kenneth Buechler
- President, Chief Executive Officer, Director
- Brian Blaser
- Chief Financial Officer
- Joseph Busky
- Interim President, Chief Operating Officer, Executive Vice President
- Robert Bujarski
- Chief Operations Officer
- Philip Mclellan
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.4B |
|---|---|
Revenue (TTM) | $2.8B |
Shares Outstanding | 67.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.08 |
EPS | $-27.89 |
Book Value | $75.05 |
P/E Ratio | -1.3x |
Price/Sales (TTM) | 0.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -64.61% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
